Back to today’s briefing

Story perspectives

NHS Approves Acarizax: New Hope for Dust Allergy Sufferers

1/30/2025

31 7

Summary

Story summary

The NHS has greenlit Acarizax, a groundbreaking daily tablet designed to combat severe dust mite allergies in those aged 12 to 65. Endorsed by NICE, this innovative treatment promises to enhance the lives of approximately 13,000 individuals in England, helping them build resilience against allergens over three years and offering new hope for those who have struggled with conventional therapies.

1 of 1

Story summary

The NHS has greenlit Acarizax, a groundbreaking daily tablet designed to combat severe dust mite allergies in those aged 12 to 65. Endorsed by NICE, this innovative treatment promises to enhance the lives of approximately 13,000 individuals in England, helping them build resilience against allergens over three years and offering new hope for those who have struggled with conventional therapies.